hoe 33342 and rolipram
hoe 33342 has been researched along with rolipram in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Felekkis, K; Flies, A; Lerner, A; Moon, EY; Sherr, DH; Tiwari, S | 1 |
Other Studies
1 other study(ies) available for hoe 33342 and rolipram
| Article | Year |
|---|---|
Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Apoptosis; B-Lymphocytes; Benzimidazoles; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Inhibitors; Fluorescent Dyes; Guanine Nucleotide Exchange Factors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Monocytes; rap1 GTP-Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; T-Lymphocytes | 2004 |